Biofrequency-Guided Nutrition in Spanish Adults

Официальное название

Application of a Frequency Measurement System for Measuring Nutritional Biomarkers: Effects of a Nutritional Intervention on Satisfaction and Improvement in Quality of Life

Обзор

The goal of this clinical trial is to evaluate the feasibility, acceptability, and preliminary efficacy of a biofrequency-guided nutritional intervention in promoting a healthy diet, improving dietary behaviors, and enhancing user satisfaction among healthy Spanish adults. The present study aims to address four main objectives: (1) to analyze the utility of the biofrequency system for non-invasive functional estimates of nutritional status; (2) to evaluate the effectiveness of the associated algorithm in generating bi-omarker-informed dietary recommendations; (3) to assess user and healthcare profes-sional acceptance and satisfaction with the tool; and (4) to examine the effects of the intervention on eating habits.

Подробное описание

Background: Biomarker-based nutrition has demonstrated superior efficacy compared to population-level approaches in improving health outcomes. Biofrequency analysis, a non-invasive technique based on the detection of electromagnetic vibrational patterns in hair follicles, offers a promising avenue for rapid functional assessment of nutritional status and epigenetic signals without reliance on blood or urine sampling. Objective: To evaluate the feasibility, acceptability, and preliminary efficacy of a biofrequency-guided nutritional intervention in promoting a healthy diet, improving dietary behaviors, and enhancing user satisfaction among healthy Spanish adults. Methods: In this randomized controlled trial, 154 adults from the Grupo Alcaraz Sport Association (Region of Murcia, Spain) will be allocated to an experimental group receiving individualized lifestyle recommendations based on S-Drive biofrequency analysis and to a control group with no intervention. Participants in the experimental arm will apply tailored dietary guidance over 90 days. Conclusion: This study will generate foundational evidence on the utility of biofrequency technology for precision nutrition. If positive, the findings may inform scalable, low-risk strategies for personalized dietary interventions in preventive and community health settings.

Вмешательства

• Другое Nutritional Intervention
  This study will follow a randomized controlled trial design aimed at evaluating the impact of nutritional intervention on personal satisfaction and perceived quality of life. The protocol includes two assessment points: a baseline measurement at the start of the intervention (Day 0) and a second measurement after a follow-up period (Day 90), allowing for the analysis of with-in-subject changes associated with the intervention.

Первичные конечные точки

• Functional Epigenetic Optimization [Срок оценки: On day 0 and day 90]

Вторичные конечные точки (10)

• Anthropometric Data [Срок оценки: On day 0 and day 90]
• 24-Hour Movement Behaviors [Срок оценки: On day 0 and day 90]
• Adherence to the Mediterranean diet (MedDiet) [Срок оценки: On day 0 and day 90]
• Tobacco smoking [Срок оценки: On day 0 and day 90]
• Alcohol consumption [Срок оценки: On day 0 and day 90]
• Cannabis use [Срок оценки: On day 0 and day 90]
• Depressive Symptoms [Срок оценки: On day 0 and day 90]
• Anxiety Symptoms [Срок оценки: On day 0 and day 90]
• Perceived stress [Срок оценки: On day 0 and day 90]
• Disordered eating [Срок оценки: On day 0 and day 90]

Критерии участия

Критерии включения

• No diagnosed chronic illnesses.
• Provision of written informed consent.

Критерии исключения

• Diagnosed chronic illnesses
• No provision of written informed consent.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Открытое

Основная цель

Другое

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT07082413 · UALBIO2025/010

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗